Table of Contents Author Guidelines Submit a Manuscript
Journal of Chemistry
Volume 2015, Article ID 672183, 7 pages
http://dx.doi.org/10.1155/2015/672183
Research Article

HPLC-Fluorescent Analysis of Memantine: An Investigation on Fluorescent Derivative Formation

Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Mahidol University, 447 Sri-Ayudhaya Road, Rajathevee, Bangkok 10400, Thailand

Received 3 December 2014; Revised 14 January 2015; Accepted 16 January 2015

Academic Editor: Ghada M. Hadad

Copyright © 2015 Pornpan Prapatpong et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. H. S. Anderson, “Alzheimer Disease,” Medscape reference, 2012, http://emedicinemedscape.com/ article/1134817-overview.
  2. Alzheimer's Association, “2013 Alzheimer's disease facts and figures,” Alzheimer's & Dementia, vol. 9, no. 2, pp. 208–245, 2013. View at Publisher · View at Google Scholar
  3. Alzheimer's Association, “Alzheimer's disease fact and figure,” Alzheimer's Disease and Dementia, vol. 8, no. 2, pp. 131–168, 2012. View at Publisher · View at Google Scholar
  4. L. Bertram and R. E. Tanzi, Progress in Molecular Biology and Translational Science, vol. 167, 2012.
  5. D. M. Walsh and D. B. Teplow, “Alzheimer's disease and the amyloid β-protein,” Progress in Molecular Biology and Translational Science, vol. 107, pp. 101–124, 2012. View at Publisher · View at Google Scholar · View at Scopus
  6. Y. Gazes, A. Soldan, and Y. Stern, Alzheimer's Disease Encyclopedia of Human Behavior, 2nd edition, 2012.
  7. J. Koppel, S. Sunday, T. E. Goldberg, P. Davies, E. Christen, and B. S. Greenwald, “Psychosis in Alzheimer's disease is associated with frontal metabolic impairment and accelerated decline in working memory: findings from the Alzheimer's disease neuroimaging initiative,” The American Journal of Geriatric Psychiatry, vol. 22, no. 7, pp. 698–707, 2014. View at Publisher · View at Google Scholar · View at Scopus
  8. D. G. Standaert and A. B. Young, “Treatment of central nervous system degenerative disorders,” in Goodman & Gilman's The Pharmacological Basis of Therapeutics, chapter 20, McGraw-Hill, New York, NY, USA, 11th edition, 2006. View at Google Scholar
  9. The United States Pharmacopeia Convention, The United States Pharmacopeia 37: The National Formula 32, The United States Pharmacopeia Convention, Rockville, Md, USA, 2014.
  10. British Pharmacopoeia, The Stationary Office, London, UK, 2015.
  11. C. Poole, Liquid Chromatography, Elsevier, Amsterdam, The Netherlands, 2013.
  12. A. Zarghi, A. Shafaati, S. M. Foroutan, A. Khoddam, and B. Madadian, “Sensitive and rapid HPLC method for determination of memantine in human plasma using OPA derivatization and fluorescence detection: application to pharmacokinetic studies,” Scientia Pharmaceutica, vol. 78, no. 4, pp. 847–856, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. C. Shuangjin, F. Fang, L. Han, and M. Ming, “New method for high-performance liquid chromatographic determination of amantadine and its analogues in rat plasma,” Journal of Pharmaceutical and Biomedical Analysis, vol. 44, no. 5, pp. 1100–1105, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. M. G. Hassan, K. M. Emara, H. A. Mohamed et al., “Determination of memantine in rat plasma by HPLC-fluorescence method and its application to study of the pharmacokinetic interaction between memantine and methazolamide,” Biomedical Chromatography, vol. 26, no. 2, pp. 214–219, 2012. View at Publisher · View at Google Scholar · View at Scopus
  15. R. F. Suckow, M. F. Zhang, E. D. Collins, M. W. Fischman, and T. B. Cooper, “Sensitive and selective liquid chromatographic assay of memantine in plasma with fluorescence detection after pre-column derivatization,” Journal of Chromatography B: Biomedical Sciences and Applications, vol. 729, no. 1-2, pp. 217–224, 1999. View at Publisher · View at Google Scholar · View at Scopus
  16. T.-H. Duh, H.-L. Wu, C.-W. Pan, and H.-S. Kou, “Fluorimetric liquid chromatographic analysis of amantadine in urine and pharmaceutical formulation,” Journal of Chromatography A, vol. 1088, no. 1-2, pp. 175–181, 2005. View at Publisher · View at Google Scholar · View at Scopus
  17. B. Narola, A. S. Singh, P. R. Santhakumar, and T. G. Chandrashekhar, “A Validated stability-indicating reverse phase hplc assay method for the determination of memantine hydrochloride drug substance with UV-detection using precolumn derivatization technique,” Analytical Chemistry Insights, vol. 2010, no. 5, pp. 37–45, 2010. View at Google Scholar · View at Scopus
  18. M.-Y. Liu, S.-N. Meng, H.-Z. Wu, S. Wang, and M.-J. Wei, “Pharmacokinetics of single-dose and multiple-dose memantine in healthy chinese volunteers using an analytic method of liquid chromatography-tandem mass spectrometry,” Clinical Therapeutics, vol. 30, no. 4, pp. 641–653, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. R. K. Konda, B. R. Challa, B. R. Chandu, and K. B. Chandrasekhar, “Bioanalytical method development and validation of memantine in human plasma by high performance liquid chromatography with tandem mass spectrometry: application to bioequivalence study,” Journal of Analytical Methods in Chemistry, vol. 2012, Article ID 101249, 8 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  20. K. Siddappa, M. Mallikarjun, T. Mahesh, K. Mallikarjun, and R. Chandrakanth, “Development and validation of a gas chromatographic method for the assay of memantine hydrochloride in pure and tablet dosage forms,” Facta Universitatis—Series: Physics, Chemistry and Technology, vol. 9, no. 1, pp. 1–8, 2011. View at Publisher · View at Google Scholar
  21. S. A. Jadhav, S. B. Landge, N. C. Niphade, S. R. Bembalkar, and V. T. Mathad, “Development and validation of stability-indicating GC-FID method for the quantitation of memantine hydrochloride and its nonchromophoric impurities in bulk and pharmaceutical dosages,” Chromatography Research International, vol. 2012, Article ID 806068, 10 pages, 2012. View at Publisher · View at Google Scholar
  22. K. Michail, H. Daabees, Y. Beltagy, M. Abdel-Khalek, and M. Khamis, “Spectrophotometric and spectrofluorimetric determination of memantine hydrochloride in bulk and pharmaceutical preparations,” International Journal of Pharmacy and Pharmaceutical Sciences, vol. 3, no. 3, pp. 180–185, 2011. View at Google Scholar · View at Scopus
  23. A. P. Rani, S. Bhawani, C. Nagalakshmi, and C. B. Sekaran, “Determination of memantine hydrochloride by spectrophotometry using anionic dyes, bromothymol blue and solochrome black Tin bulk and tablet dosage forms,” Journal of Chemical Sciences, vol. 2012, p. CSJ-60, 2012. View at Google Scholar
  24. K. Imai, T. Fukushima, and H. Yokosu, “A novel electrophilic reagent, 4-(N-chloroformylmethyl-N-methyl)amino-7-N,N-dimethylaminosulphonyl-2, 1,3-benzoxadiazole (DBD-COCI) for fluorometric detection of alcohols, phenols, amines and thiols,” Biomedical Chromatography, vol. 8, no. 3, pp. 107–113, 1994. View at Publisher · View at Google Scholar · View at Scopus